Cardiology Flashcards
Components of Atherosclerosis
Atherosclerosis affects the medium and large arteries. It is caused by chronic inflammation and activation of the immune system in the artery wall. This causes the deposition of lipids in the artery wall, followed by the development of fibrous atheromatous plaques.
These plaques result in:
Stiffening
Stenosis
Plaque rupture
Stiffening of the artery walls leads to hypertension (raised blood pressure) and strain on the heart as it tries to pump blood against extra resistance.
Stenosis leads to reduced blood flow (e.g. in angina).
Plaque rupture creates a thrombus that can block a distal vessel and cause ischaemia. An example is acute coronary syndrome, where a coronary artery becomes blocked.
Non-modifiable and modifiable risk factors of cardiovascular disease
Non-modifiable risk factors:
Older age
Family history
Male
Modifiable risk factors:
Raised cholesterol
Smoking
Alcohol consumption
Poor diet
Lack of exercise
Obesity
Poor sleep
Stress
Medical Co-Morbidities of cardiovascular disease
Diabetes
Hypertension
Chronic kidney disease (CKD)
Inflammatory conditions, such as rheumatoid arthritis
Atypical antipsychotic medications
Complications of atherosclerosis
Angina
Myocardial infarction
Transient ischaemic attacks
Strokes
Peripheral arterial disease
Chronic mesenteric ischaemia
Primary Prevention of Cardiovascular Disease
Medication for primary prevention is based on the QRISK3 score.
The QRISK score estimates the percentage risk that a patient will have a stroke or myocardial infarction in the next 10 years. The NICE guidelines (updated February 2023) recommend when the result is above 10%, they should be offered a statin, initially atorvastatin 20mg at night.
Atorvastatin 20mg is offered as primary prevention to all patients with:
Chronic kidney disease (eGFR less than 60 ml/min/1.73 m2)
Type 1 diabetes for more than 10 years or are over 40 years
The draft NICE guidelines due for publication in mid-2023 advise that atorvastatin 20mg can be considered for primary prevention in patients with a QRISK3 score below 10%.
Statins
Statins reduce cholesterol production in the liver by inhibiting HMG CoA reductase.
NICE recommend checking lipids 3 months after starting statins and increasing the dose to aim for a greater than 40% reduction in non-HDL cholesterol. Check adherence (are they taking the medications?) before increasing the dose.
NICE also recommend checking LFTs within 3 months of starting a statin and again at 12 months. Statins can cause a transient and mild rise in ALT and AST in the first few weeks of use. They usually do not need to be stopped if the rise is less than 3 times the upper limit of normal.
Side effects of statins
Myopathy (causing muscle weakness and pain)
Rhabdomyolysis (muscle damage – check the creatine kinase in patients with muscle pain)
Type 2 diabetes
Haemorrhagic strokes (very rarely)
Usually, the benefits of statins far outweigh the risks, and newer statins (such as atorvastatin) are well tolerated.
TOM TIP: Several common medications interact with statins. One key interaction to remember is with macrolide antibiotics. Patients being prescribed clarithromycin or erythromycin should be advised to stop taking their statin whilst taking these antibiotics.
Cholesterol Lowering Drugs
Ezetimibe works by inhibiting the absorption of cholesterol in the intestine. It can be used as an alternative when statins are not tolerated or in combination with a statin when statins alone are inadequate.
PCSK9 inhibitors (e.g., evolocumab and alirocumab) are monoclonal antibodies that lower cholesterol. They are highly specialist treatments, given as a subcutaneous injection every 2-4 weeks.
Secondary Prevention of Cardiovascular Disease
A – Antiplatelet medications (e.g., aspirin, clopidogrel and ticagrelor)
A – Atorvastatin 80mg
A – Atenolol (or an alternative beta blocker – commonly bisoprolol) titrated to the maximum tolerated dose
A – ACE inhibitor (commonly ramipril) titrated to the maximum tolerated dose
MI treatment
Aspirin 75mg daily (continued indefinitely)
Clopidogrel or ticagrelor (generally for 12 months before stopping)
Ischaemic stroke
Clopidogrel is the antiplatelet of choice in peripheral arterial disease and following an ischaemic stroke.
Familial Hypercholesterolaemia
Familial hypercholesterolaemia is an autosomal dominant genetic condition causing very high cholesterol levels. Several genes have the potential to cause the disorder.
Heterozygous means only one copy of the gene is abnormal. This occurs in about 1 in 250 people.
Homozygous means both copies of the gene are abnormal. This very rare condition causes extremely high cholesterol (over 13 mmol/L) and almost guaranteed early cardiovascular disease.
The Simon Broome criteria or the Dutch Lipid Clinic Network Criteria are used for making a clinical diagnosis. Three important features to remember are:
Family history of premature cardiovascular disease (e.g., myocardial infarction under 60 in a first-degree relative)
Very high cholesterol (e.g., above 7.5 mmol/L in an adult)
Tendon xanthomata (hard nodules in the tendons containing cholesterol, often on the back of the hand and Achilles)
Treating familial hypercholesterolaemia
Management of familial hypercholesterolaemia involves:
Specialist referral for genetic testing and testing of family members
Statins
What causes angina?
Angina is caused by atherosclerosis affecting the coronary arteries, narrowing the lumen (inside diameter) and reducing blood flow to the myocardium (heart muscle). During times of high demand, such as exercise, there is an insufficient supply of blood to meet the demand. This causes the symptoms of angina, typically constricting chest pain, with or without radiation to the jaw or arms.
Define stable angina
Angina is “stable” when symptoms only come on with exertion and are always relieved by rest or glyceryl trinitrate (GTN).
Define unstable angina
It is “unstable” when the symptoms appear randomly whilst at rest. Unstable angina is a type of acute coronary syndrome (ACS) and requires immediate management.
Investigations for angina
All patients with angina should have the following baseline investigations:
Physical examination (e.g., heart sounds, signs of heart failure, blood pressure and BMI)
ECG (a normal ECG does not exclude stable angina)
FBC (anaemia)
U&Es (required before starting an ACE inhibitor and other medications)
LFTs (required before starting statins)
Lipid profile
Thyroid function tests (hypothyroidism or hyperthyroidism)
HbA1C and fasting glucose (diabetes)
Cardiac stress testing, dobutamine, ECG, echocardiogram, MRI or a myocardial perfusion scan (nuclear medicine scan).
CT coronary angiography involves injecting contrast and taking CT images timed with the heart contractions to give a detailed view of the coronary arteries, highlighting the specific locations of any narrowing.
Invasive coronary angiography involves an invasive procedure performed in a catheter laboratory (cath lab). A catheter is inserted into the patient’s brachial or femoral artery, directed through the arterial system to the aorta and the coronary arteries under x-ray guidance, where contrast is injected to visualise the coronary arteries and identify any areas of stenosis using x-ray images. This is considered the gold standard for determining coronary artery disease.
Management of stable angina
R – Refer to cardiology
A – Advise them about the diagnosis, management and when to call an ambulance
M – Medical treatment
P – Procedural or surgical interventions
S – Secondary prevention
Referrals are usually sent to the rapid access chest pain clinic (RACPC).
Medical management of stable angina
Immediate symptomatic relief during episodes of angina
Long-term symptomatic relief
Secondary prevention of cardiovascular disease
Immediate symptomatic relief of stable angina
Sublingual glyceryl trinitrate (GTN) in the form of a spray or tablets. GTN causes vasodilation, improving blood flow to the heart muscle (myocardium). Patients are advised to:
Take the GTN when the symptoms start
Take a second dose after 5 minutes if the symptoms remain
Take a third dose after a further 5 minutes if the symptoms remain
Call an ambulance after a further 5 minutes if the symptoms remain
Key side effects of GTN are headaches and dizziness caused by vasodilation.
Long-term symptomatic relief of stable angina
Beta blocker (e.g., bisoprolol)
Calcium-channel blocker (e.g., diltiazem or verapamil – both avoided in heart failure with reduced ejection fraction)
A specialist may consider other options for long-term symptomatic relief:
Long-acting nitrates (e.g., isosorbide mononitrate)
Ivabradine
Nicorandil
Ranolazine
Surgical interventions for stable angina
Surgical procedures are generally offered to patients with more severe disease and where medical treatments do not control symptoms. There are two options:
Percutaneous coronary intervention (PCI)
Coronary artery bypass graft (CABG)
Percutaneous coronary intervention (PCI) involves inserting a catheter into the patient’s brachial or femoral artery. This is fed in, under x-ray guidance, through the arterial system to the coronary arteries. Then a contrast is injected to visualise the coronary arteries and identify areas of stenosis on the x-ray images. Areas of stenosis can be treated by dilating a balloon to widen the lumen (angioplasty) and inserting a stent to keep it open. This can be referred to as coronary angioplasty and stenting.
Coronary artery bypass graft (CABG) surgery may be offered to patients with severe stenosis. This involves opening the chest along the sternum, with a midline sternotomy incision. A graft vessel is attached to the affected coronary artery, bypassing the stenotic area. The three main options for graft vessels are:
Saphenous vein (harvested from the inner leg)
Internal thoracic artery, also known as the internal mammary artery
Radial artery
PCI versus CABG
PCI:
Faster recovery
Lower rate of strokes as a complication
Higher rate of requiring repeat revascularisation (further procedures)
TOM TIP: When examining a patient that you think may have coronary artery disease in your OSCEs, check for a midline sternotomy scar (previous CABG), scars around the brachial and femoral arteries (previous PCI) and along the inner calves (saphenous vein harvesting scar) to see what procedures they may have had done.
Thrombus
When a thrombus forms in a fast-flowing artery, it is formed mainly of platelets. This is why antiplatelet medications such as aspirin, clopidogrel and ticagrelor are the mainstay of treatment.